Ezetimibe and the risk of new-onset type 2 diabetes: a systematic review and meta-analysis

Background Statins reduce cardiovascular risk but may increase new-onset type 2 diabetes mellitus (NO-T2DM). Ezetimibe, a cholesterol absorption inhibitor, is often added to statins to improve lipid control, yet its impact on NO-T2DM remains uncertain.Objective This systematic review evaluated moder...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Areej S. Albawa’neh, Mais N. Alqasrawi, Zeina N. Al-Mahayri, Amal Albawaana, Gamila Ahmed, Rami H. Al-Rifai, Bassam R. Ali
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Taylor & Francis Group 2025-12-01
Saila:	Annals of Medicine
Gaiak:	Statins ezetimibe T2DM diabetes mellitus lipids
Sarrera elektronikoa:	https://www.tandfonline.com/doi/10.1080/07853890.2025.2594355
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!